[Asia Economy Reporter Minwoo Lee] Hwail Pharmaceuticals announced on the 17th that the largest shareholder has changed from Dinona and three others to Kumho HT and three others. The company explained, "The change is due to the merger between Kumho HT and Dinona."



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing